Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.

@article{Deplanque2004StrokePA,
  title={Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.},
  author={Dominique Deplanque and Didier Leys and Lucilla Parnetti and Reinhold Schmidt and Jos{\'e} {\'A}ngel Santos Ferro and Jacques De Reuck and J. Mas and Virgilio Gallai},
  journal={British journal of clinical pharmacology},
  year={2004},
  volume={57 6},
  pages={
          798-806
        }
}
AIMS The aim of the Stroke and Atrial Fibrillation Ensemble (SAFE) II study was to identify the reasons underlying the under-utilization of oral anticoagulation (OAC) in patients with nonvalvular atrial fibrillation (NVAF). METHODS We investigated from all available sources the reasons why patients hospitalized for a stroke, who had a previously known NVAF, were not receiving OAC beforehand. We interviewed general practitioners (GPs) and cardiologists with a structured questionnaire, to… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 55 CITATIONS, ESTIMATED 41% COVERAGE

Atrial fibrillation (AF) and co-morbidity in elderly. A population based survey of 85 years old subjects.

  • Archives of gerontology and geriatrics
  • 2011
VIEW 2 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial Fibrillation.

  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2005
2018

CITATION STATISTICS

  • 2 Highly Influenced Citations